资讯

Fierce Pharma49 分钟
Amid $15B AstraZeneca partnership rumor, Summit needs $7.7B upfront to excite investors ...
After several PD-1xVEGF competitors forged alliances with Big Pharma players, Summit Therapeutics, the frontrunner in this hot cancer drug field, is reportedly seeking its own deal. | After several PD ...